Troux Wins $1.4M Pharmaceuticals Win

Austin, Texas-based IT planning software developer Troux Technologies revealed Tuesday that a global pharmaceutical firm is using multiple Troux applications to power that company's business transformation program. Though Troux declined to disclose the name of its new customer, it did list AstraZeneca among its key clientele. Whoever the pharmaceutical firm is, Troux noted that its business represents more than a $1.4 million investment and includes the licensing of the Troux 7 Transformation Platform as well as the Troux Standards and Troux Applications utilities. The latter two programs, Troux explained, will help the client rationalize its IT applications, reduce costs and manage software standards.